TWEAK
TWEAK (TNF superfamily member 12, also known as TNFSF12, DR3LG, APO3L and TNF12) is a cytokine of the tumour necrosis factor ligand family. It binds the FN14/TWEAKR receptor and regulates NF-kappa-B signalling, angiogenesis and inflammatory cytokine induction. Browse Assay Genie's current range of TWEAK research reagents below, or read on for the biology behind the target.
TWEAK is a cytokine that belongs to the tumour necrosis factor (TNF) ligand family. It acts as a ligand for the FN14/TWEAKR receptor and, according to UniProt, possibly also for TNFRSF12/APO3. Through this signalling it mediates NF-kappa-B activation, promotes angiogenesis and the proliferation of endothelial cells, and is involved in the induction of inflammatory cytokines, including the promotion of IL-8 secretion.
The protein exists in both membrane-bound and secreted forms. It has overlapping signalling functions with TNF but displays a much wider tissue distribution. TWEAK is also described as a weak inducer of apoptosis in some cell types, and it can trigger cell death through multiple pathways in a cell type-specific manner. It promotes both proliferation and migration of endothelial cells, which is why it is regarded as a regulator of angiogenesis.
The human TWEAK gene is named TNFSF12, with the previous name tumour necrosis factor (ligand) superfamily, member 12, and the mouse ortholog is Tnfsf12. Alternative splicing produces multiple transcript variants. Some transcripts skip the last exon of the gene and continue into the second exon of the neighbouring TNFSF13 gene; these read-through transcripts are catalogued separately as TNFSF12-TNFSF13. Researchers studying the TWEAK protein or the TNFSF12 gene should take these variants into account when interpreting expression data.
TWEAK promotes endothelial cell proliferation and migration, making it a regulator of angiogenesis to study in vascular biology.
TWEAK mediates NF-kappa-B activation through its receptor FN14, providing a route into this signalling pathway.
TWEAK is involved in inducing inflammatory cytokines and promotes IL-8 secretion, linking it to inflammatory responses.
TWEAK can induce apoptosis through multiple pathways in a cell type-specific manner, though it is a weak inducer in some cells.
TWEAK is a TNF family cytokine that binds the FN14/TWEAKR receptor. It mediates NF-kappa-B activation, promotes angiogenesis and endothelial cell proliferation, contributes to induction of inflammatory cytokines and promotes IL-8 secretion. It is also a weak inducer of apoptosis in some cell types.
The gene symbol is TNFSF12, and aliases include DR3LG, APO3L and TNF12. The UniProt name is tumour necrosis factor ligand superfamily member 12. The protein occurs in membrane-bound and secreted forms, and alternative splicing yields multiple transcript variants, including TNFSF12-TNFSF13 read-through transcripts.
A mouse ortholog, Tnfsf12, exists. TWEAK belongs to the TNF ligand family and has overlapping signalling functions with TNF, but displays a much wider tissue distribution. Check the datasheet of any product for its validated reactivity.
Other TNF superfamily ligands with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43508; product specifications from Assay Genie datasheets.